BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) to Present Scientific Findings at New York Conferences
BriaCell is set to present clinical and scientific data on its findings in biomarker analyses from the clinical trials it has so far conducted; the presentations will take place at the upcoming conferences in New York The clinical efficacy data, which will be made public in advance of these conferences, is crucial to BriaCell, because it helps advance the company’s BriaDX diagnostic test solution; BriaDX is used in determining the kind of patients with a high likelihood of responding to advanced breast cancer treatment BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) is a clinical-stage biotechnology company based in Berkeley, California.…